Cara Therapeutics reported $53K in Ordinary Share Capital for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Acadia Pharmaceuticals ACAD:US USD 16K 0
Acelrx Pharmaceuticals ACRX:US USD 7K 140K
Cara Therapeutics CARA:US USD 53K 0
Chugai Pharma 4519:JP JPY 73.2B 0
Depomed DEPO:US USD 5K 0
Endo International Ordinary Shares ENDP:US USD 63K 3K
Halozyme Therapeutics HALO:US USD 135K 0
Horizon Pharma HZNP:US USD 23K 0
Neurocrine Biosciences NBIX:US USD 100K 0
Pacira Pharmaceuticals PCRX:US USD 46K 0
Pain Therapeutics PTIE:US USD 42K 2K
Revance Therapeutics RVNC:US USD 82K 0
Supernus Pharmaceuticals SUPN:US USD 54K 0
Teva Pharmaceutical Industries TEVA:US USD 57M 0
Vanda Pharmaceuticals VNDA:US USD 57K 0